Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare ...

As previously stated, the company has engaged in a new round of discussions with the US FDA to finalize the development plan for ADV7103 in cystinuria in the United States. During the latest ...

Cystine stones (less than 1 percent of stones) Cystine is an amino acid that is in certain foods; it is one of the building blocks of protein. Cystinuria (too much cystine in the urine) is a rare, ...

Analysts at Leerink Partnrs lifted their FY2026 earnings estimates for Travere Therapeutics in a research report issued to ...

Urine microscopy is an important adjunct to the urinalysis. The findings of cells, casts or crystals can aid in urinalysis interpretation and in making a more accurate diagnosis. Since the formed ...

Background: Alkyl ester quaternary ammonium compounds (ester quats) are used extensively in fabric rinse conditioners. It is important to document in the literature the outcome of historical ...

Investment analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for Travere Therapeutics in a note issued to investors on Wednesday, January 15th. HC Wainwright analyst E.